News

Published on 7 May 2024 on GuruFocus.com via Yahoo Finance

Strategic Shifts in Tweedy Browne's Portfolio Highlight FMC Corp's Significant Reduction


Article preview image

Insights from the First Quarter of 2024 13F Filing

Tweedy Browne (Trades, Portfolio), a distinguished investment firm with a rich history dating back to its association with Benjamin Graham in the mid-20th century, continues to make strategic moves in the financial markets. Managed by a seasoned team with decades of experience, the firm adheres to a value investing philosophy, focusing on undervalued securities in developed markets and aiming for long-term capital growth. The recent 13F filing for the first quarter of 2024 reveals significant transactions that underline the firm's investment strategy and market outlook.

NASDAQ.IONS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Why Is Ionis Pharmaceuticals, Inc. (IONS) Among the Worst Performing Biotech...

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, w...

Insider Monkey · via Yahoo Finance 21 Nov 2024

Ionis Pharmaceuticals, Inc. (IONS): Among the Best Genomics Stocks to Buy Right...

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we ...

Insider Monkey · via Yahoo Finance 19 Nov 2024

Ionis Pharmaceuticals Inc (IONS) Q3 2024 Earnings Call Highlights: Navigating...

Despite a dip in quarterly revenue, Ionis Pharmaceuticals Inc (IONS) focuses on upcoming product...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

Ionis Pharmaceuticals, Inc. (IONS): Among The Stocks With Biggest Upside...

We recently compiled a list of the 10 Stocks with Biggest Upside Potential According to Hedge Fun...

Insider Monkey · via Yahoo Finance 7 Oct 2024

Insider Sale at Ionis Pharmaceuticals Inc (IONS) by EVP, Chief Development...

Following this sale, the insider now owns 85,508 shares of Ionis Pharmaceuticals Inc. Over the pa...

GuruFocus.com · via Yahoo Finance 20 Aug 2024

Shareholders Will Probably Not Have Any Issues With Ionis Pharmaceuticals,...

Key Insights Ionis Pharmaceuticals' Annual General Meeting to take place on 6th of June Salary of...

Simply Wall St. · via Yahoo Finance 19 May 2024

The Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) First-Quarter Results Are Out And Analysts Have...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) shareholders are probably feeling a little disappointed...

Simply Wall St. via Yahoo Finance 9 May 2024

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript May 7, 2024 Ionis Phar...

Insider Monkey via Yahoo Finance 9 May 2024

Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss

Ionis Pharmaceuticals IONS reported a loss of 98 cents per share for first-quarter 2024, which wa...

Zacks via Yahoo Finance 8 May 2024

Strategic Shifts in Tweedy Browne's Portfolio Highlight FMC Corp's Significant Reduction

Insights from the First Quarter of 2024 13F Filing Tweedy Browne (Trades, Portfolio), a distingui...

GuruFocus.com via Yahoo Finance 7 May 2024